These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 26696258)
1. Drugs Targeting the Canonical NF-κB Pathway to Treat Viral and Autoimmune Myocarditis. Valaperti A Curr Pharm Des; 2016; 22(4):440-9. PubMed ID: 26696258 [TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation. Azuma RW; Suzuki J; Ogawa M; Futamatsu H; Koga N; Onai Y; Kosuge H; Isobe M Cardiovasc Res; 2004 Dec; 64(3):412-20. PubMed ID: 15537494 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of NF-κB activation by a novel IKK inhibitor reduces the severity of experimental autoimmune myocarditis via suppression of T-cell activation. Watanabe R; Azuma RW; Suzuki J; Ogawa M; Itai A; Hirata Y; Komuro I; Isobe M Am J Physiol Heart Circ Physiol; 2013 Dec; 305(12):H1761-71. PubMed ID: 24097428 [TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade. Yuan Z; Liu Y; Liu Y; Zhang J; Kishimoto C; Wang Y; Ma A; Liu Z Heart; 2005 Sep; 91(9):1203-8. PubMed ID: 15774612 [TBL] [Abstract][Full Text] [Related]
5. Lipoxin A4 mitigates experimental autoimmune myocarditis by regulating inflammatory response, NF-κB and PI3K/Akt signaling pathway in mice. Shi Y; Pan H; Zhang HZ; Zhao XY; Jin J; Wang HY Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1850-1859. PubMed ID: 28485793 [TBL] [Abstract][Full Text] [Related]
6. Future therapeutic strategies in inflammatory cardiomyopathy: insights from the experimental autoimmune myocarditis model. Blyszczuk P; Valaperti A; Eriksson U Cardiovasc Hematol Disord Drug Targets; 2008 Dec; 8(4):313-21. PubMed ID: 19075632 [TBL] [Abstract][Full Text] [Related]
7. Nuclear factor-kappaB decoy: infiltrating the heart of the matter in inflammatory heart disease. Liu PP; Le J; Nian M Circ Res; 2001 Nov; 89(10):850-2. PubMed ID: 11701609 [No Abstract] [Full Text] [Related]
8. NF-kappa B as a therapeutic target in autoimmune disease. O'Sullivan B; Thompson A; Thomas R Expert Opin Ther Targets; 2007 Feb; 11(2):111-22. PubMed ID: 17227228 [TBL] [Abstract][Full Text] [Related]
10. PPAR-gamma ligands inhibit the expression of inflammatory cytokines and attenuate autoimmune myocarditis. Yuan ZY; Liu Y; Liu Y; Zhang JJ; Kishimoto C; Wang YN; Ma AQ; Liu ZQ Chin Med J (Engl); 2004 Aug; 117(8):1253-5. PubMed ID: 15361304 [No Abstract] [Full Text] [Related]
11. [Immunosuppressive therapy in myocarditis and dilated cardiomyopathy?]. Schultheiss HP Internist (Berl); 1992 Oct; 33(10):650-62. PubMed ID: 1428684 [No Abstract] [Full Text] [Related]
12. Endoplasmic Reticulum Stress Aggravates Viral Myocarditis by Raising Inflammation Through the IRE1-Associated NF-κB Pathway. Zha X; Yue Y; Dong N; Xiong S Can J Cardiol; 2015 Aug; 31(8):1032-40. PubMed ID: 26111668 [TBL] [Abstract][Full Text] [Related]
13. Oleuropein prevents the development of experimental autoimmune myocarditis in rats. Zhang JY; Yang Z; Fang K; Shi ZL; Ren DH; Sun J Int Immunopharmacol; 2017 Jul; 48():187-195. PubMed ID: 28525856 [TBL] [Abstract][Full Text] [Related]
14. Suppression of cytokines and nitric oxide production, and protection against lethal endotoxemia and viral myocarditis by a new NF-kappaB inhibitor. Matsumori A; Nunokawa Y; Yamaki A; Yamamoto K; Hwang MW; Miyamoto T; Hara M; Nishio R; Kitaura-Inenaga K; Ono K Eur J Heart Fail; 2004 Mar; 6(2):137-44. PubMed ID: 14984720 [TBL] [Abstract][Full Text] [Related]
16. Curcumin ameliorates cardiac inflammation in rats with autoimmune myocarditis. Mito S; Watanabe K; Harima M; Thandavarayan RA; Veeraveedu PT; Sukumaran V; Suzuki K; Kodama M; Aizawa Y Biol Pharm Bull; 2011; 34(7):974-9. PubMed ID: 21720000 [TBL] [Abstract][Full Text] [Related]
17. Telmisartan ameliorates experimental autoimmune myocarditis associated with inhibition of inflammation and oxidative stress. Sukumaran V; Watanabe K; Veeraveedu PT; Ma M; Gurusamy N; Rajavel V; Suzuki K; Yamaguchi K; Kodama M; Aizawa Y Eur J Pharmacol; 2011 Feb; 652(1-3):126-35. PubMed ID: 21115000 [TBL] [Abstract][Full Text] [Related]
18. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease. Martín R; Cordova C; San Román JA; Gutierrez B; Cachofeiro V; Nieto ML J Mol Cell Cardiol; 2014 Jul; 72():250-62. PubMed ID: 24732212 [TBL] [Abstract][Full Text] [Related]
19. cis Element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats. Yokoseki O; Suzuki J; Kitabayashi H; Watanabe N; Wada Y; Aoki M; Morishita R; Kaneda Y; Ogihara T; Futamatsu H; Kobayashi Y; Isobe M Circ Res; 2001 Nov; 89(10):899-906. PubMed ID: 11701617 [TBL] [Abstract][Full Text] [Related]